Epigenetic clocks: how DNA methylation is used to estimate biological age
A video description explains how epigenetic clocks use DNA methylation patterns to estimate biological age, how first- to third-generation clocks differ, and that accelerated epigenetic age is associated with higher disease and mortality risk. Different clocks can disagree, and there is no single gold standard. [1]
Automatic summary · not editorially reviewed
The key findings
The description says DNA methylation patterns change predictably with age and form the basis of epigenetic clocks. [1]
Horvath’s clock uses 353 CpG sites, Hannum’s uses 71 CpG sites from blood, and DunedinPACE measures the rate of aging. [1]
Epigenetic age acceleration is associated with higher risk of cardiovascular disease, cancer, dementia and all-cause mortality. [1]
The source at a glance
- Study type / format
- Video description summarizing epigenetic clock research; no specific study design reported.
- Population / context
- Not specified in the description; DunedinPACE is said to have been trained on the Dunedin birth cohort and validated across multiple populations.
- Summary based on
- Creator description
- Original publication
- October 22, 2026
Described clocks and what they are meant to measure
The description presents epigenetic clocks as tools that read biological age from DNA. DNA methylation means methyl groups are added to cytosine nucleotides and regulate gene expression; specific patterns change predictably with age, which the description calls the basis of these clocks. It names first-generation clocks (Horvath, Hannum), second-generation clocks (PhenoAge, GrimAge) and a third-generation clock (DunedinPACE).
Supporting source [1]
How the named clocks differ in sites and output
According to the description, Horvath’s clock covers many tissues and uses 353 CpG sites, while Hannum’s clock uses 71 CpG sites from blood. PhenoAge is said to predict morbidity and mortality better than chronological age, and GrimAge to predict lifespan and healthspan. DunedinPACE is described as measuring the rate of aging per year of chronological time rather than how old someone is biologically.
Supporting source [1]
Accelerated epigenetic age linked to disease risk, not proven cause
The description states that epigenetic age acceleration — biological age greater than chronological age — is associated with increased risk of cardiovascular disease, cancer, dementia and all-cause mortality. DunedinPACE was trained on the Dunedin birth cohort and validated across multiple populations. The description also notes that different clocks can give different results for the same person and that there is no single gold standard. These are associations, not evidence that a clock reading causes disease.
Supporting source [1]
How to interpret this
This explainer is based only on the video description. The video and transcript were not reviewed, so study designs, samples, follow-up and effect sizes are not reported here. The description mentions validation studies and cohort training without giving details. Associations described are not proof of cause.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
itinai · youtube.com · October 22, 2026